Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy

Completed · Phase 3

Conditions studied: Knee Injury

In brief

If preservative-free dexamethasone 0.1 mg/kg (max dose 4 mg) is added to ropivacaine 0.5% 2 mg/kg (max dose 100 mg), then post-PACU opioid consumption will be reduced by 33%.

Key facts

Study ID

NCT01971645

Run by

Nationwide Children's Hospital

People needed

77

Starts

2014-07-01

Expected to finish

2016-09-01

Last updated by the study team

2018-12-11

Who can join

Age: 10 and older, up to 19. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children older than 10, and younger than 19 years of age undergoing unilateral arthroscopic surgery of the knee
• American Society of Anesthesiologists (ASA) Status I or II
• Patient's parent/guardian willing and able to give consent
• Patient willing to give assent

You may not qualify if…

• Arthroscopic anterior cruciate ligament repair
• Systemic steroid use within the last 3 months
• Diabetes mellitus
• Females testing positive for pregnancy
• BMI > 98th percentile
• Positive pregnancy test
• Coagulopathy
• Renal or hepatic disease
• Pre-existing motor or sensory deficits in the lower extremities
• Predisposition for falls based on pre-existing sensory or motor deficits of the legs or inability to perform crutch training.
• Non-English speaking
• Systemic fungal infection
• Immunosuppressed patients

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.